 |
|
2020 KSC/KATRD Guideline for the Diagnosis and Treatment of Pulmonary Hypertension: Executive Summary
Jae-Hyeong Park, Jin Oh Na, Jae Seung Lee, Yee Hyung Kim, Hyuk-Jae Chang,
Tuberc Respir Dis. 2022;85(1):1-10. Published online 2021 Jun 4 DOI: https://doi.org/10.4046/trd.2021.0022
|
|
Citations to this article as recorded by
 Ginsenoside Rg1 alleviates vascular remodeling in hypoxia-induced pulmonary hypertension mice through the calpain-1/STAT3 signaling pathway
Chenyang Ran, Meili Lu, Fang Zhao, Yi Hao, Xinyu Guo, Yunhan Li, Yuhong Su, Hongxin Wang
Journal of Ginseng Research.2024;[Epub] CrossRef Diagnostic Value of Serum Galectin-3 Binding Protein Level in Patients
with Pulmonary Arterial Hypertension
Mingfei Li, Wenzhi Pan, Dan Tian, Dandan Chen, Xiaochun Zhang, Yuan Zhang, Shasha Chen, Daxin Zhou, Junbo Ge
Current Vascular Pharmacology.2024; 22(1): 67. CrossRef Risk Stratification in Pulmonary Arterial Hypertension, Update and Perspectives
Argyro Vraka, Eleni Diamanti, Mithum Kularatne, Patrick Yerly, Frédéric Lador, John-David Aubert, Benoit Lechartier
Journal of Clinical Medicine.2023; 12(13): 4349. CrossRef Exercise-induced desaturation during a six-minute walk test is associated with poor clinical outcomes in patients with pulmonary arterial hypertension
Jung Hyun Choi, Myung-Jun Shin, Byeong-Ju Lee, Jae-Hyeong Park
Clinical Hypertension.2023;[Epub] CrossRef Study on the Agreement Values of Pulmonary Arterial Hypertension Measured by Cardiac Sonographers
Seol Hwa KIM, Sundo JUNG
Korean Journal of Clinical Laboratory Science.2023; 55(4): 269. CrossRef Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia
James J. Anderson, Edmund M. Lau
JACC: Asia.2022; 2(5): 538. CrossRef Clinical application of risk assessment in PAH: Expert center APRN recommendations
Melisa Wilson, Jennifer Keeley, Martha Kingman, Susanne McDevitt, Jacqueline Brewer, Frances Rogers, Wendy Hill, Zachary Rideman, Meredith Broderick
Pulmonary Circulation.2022;[Epub] CrossRef
|